Evidence map›Paper›PMID 33842199›Full record

ArticlePreventive medicine reports2021

Results of a prospective cardiovascular disease prevention program.

Arn Eliasson, Mariam Kashani, Marina Vernalis

Abstract read
In one paragraph

Article in Preventive medicine reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Arn EliassonCardiovascular Health Program Registry, Henry M. Jackson Foundation for the Advancement of Military Medicine, 6720A Rockledge Drive, Bethesda, MD 20817, United States.
Mariam KashaniCardiovascular Health Program Registry, Henry M. Jackson Foundation for the Advancement of Military Medicine, 6720A Rockledge Drive, Bethesda, MD 20817, United States.
Marina VernalisCardiovascular Health Program Registry, Henry M. Jackson Foundation for the Advancement of Military Medicine, 6720A Rockledge Drive, Bethesda, MD 20817, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Cardiovascular Health Program (CHP) Registry is a 12-month, prospective study of therapeutic lifestyle change (TLC). Adult participants received comprehensive assessment of health behaviors and cardiovascular disease (CVD) risk factors. Personalized TLC action plans addressed modifiable health behaviors for diet, exercise, stress management, and sleep. Participants attended a half-day interactive workshop and met face-to-face with certified health coaches four times over 6 months. Monthly telephonic coaching for 6 more months completed the intervention. Measured outcomes included adherence to behavioral prescriptions, anthropometrics, CVD-relevant laboratory tests, and for a subset of participants, carotid intima-media thickness (CIMT). Of 965 participants, 648 (67%) completed the program and were included in the analysis. Participants were of mean age 55.4 ± 12.5 years, 57% women, and racially diverse. Adherence to prescribed TLC was substantial: dietary behaviors at goal rose from 53% to 86%, exercise 44% to 66%, perceived stress 65% to 79%, and sleep quality 28% to 49%. For participants with abnormal anthropometrics at baseline, there were improvements in body mass index in 63%, waist circumference (men 71%, women 74%), systolic BP 69%, and diastolic BP 71%. For participants with abnormal laboratory values at baseline, there were improvements in total cholesterol in 74%, LDL-cholesterol 65%, triglycerides 86%, fasting glucose 72%, and insulin resistance 71%. Improvements were not driven by prescribed medications. CIMT improved or showed no change in 70% of those measured, associated with significant improvements in sleep quality and longer total sleep time. Longer trials incorporating controls and major adverse CVD events are warranted.

Indexed as

ACEi, angiotensin converting enzyme inhibitorARB, angiotensin receptor blockerBehavioral interventionBMI, body mass index in kg/m2BP, blood pressureCardiovascular diseaseCardiovascular riskCCB, calcium channel blockerCHP, Cardiovascular Health ProgramCIMT, carotid intima-media thicknessCLIA, Clinical Laboratory Improvement AmendmentsDias BP, diastolic blood pressure in mm HgDPP4, mdipeptidyl peptidase 4 inhibitorESS, Epworth Sleepiness ScaleFBG, fasting blood glucose in mg/dLHOMA-IR, homeostatic model assessment for insulin resistanceIPAQ, International Physical Activity QuestionnaireIRB, institutional review boardLDL, low density lipoproteinMACE, major adverse cardiovascular eventsNDRI, nicotine and dopamine reuptake inhibitorNP, nurse practitionerPreventionPSQI, Pittsburgh Sleep Quality IndexPSS, Perceived Stress ScaleRYP, Rate-Your-PlateSARI, serotonin antagonist and reuptake inhibitorSD, standard deviationSNRI, serotonin-norepinephrine reuptake inhibitorSPSS, Statistical Package for the Social ScienceSSRI, selective serotonin reuptake inhibitorStatin, HMG-CoA reductase inhibitorSys BP, systolic blood pressure in mm HgTCA, tricyclic antidepressantTherapeutic lifestyle changeTLC, therapeutic lifestyle changeTot Chol, total cholesterol in mg/dLTrig, triglycerides in mg/dLWC, waist circumference in cmα Blocker, alpha blockerβ blocker, beta blocker

Identifiers

PMID33842199
PMCPMC8020477

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.